Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Current Oral Health Reports
Erschienen in: Current Oral Health Reports 2/2018

01.06.2018 | Oral Disease and Nutrition (F Nishimura, Section Editor)

Reciprocal Interactions Among OSA, Obesity, and Sleep Duration

verfasst von: Kazuo Chin, Ryo Tachikawa

Erschienen in: Current Oral Health Reports | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Obesity has become a serious public health concern worldwide in recent decades. Obesity is the most important factor in and a predictor of obstructive sleep apnea (OSA), and as high as 70% of patients with OSA are obese. The purpose of this review was to investigate reciprocal interactions among OSA, obesity, and sleep duration from recent studies.

Recent Findings

It was thought that chronic intermittent hypoxia and sleep fragmentation over the years in persons with sleep apnea could lead to changes in central control of energy regulation. There is an emerging concept that OSA itself may in turn reinforce the obese state. Given the plausible reciprocal relationship between obesity and OSA, treating OSA with continuous positive airway pressure (CPAP) could be thought to act against weight gain as previously reported. However, recent studies revealed that CPAP therapy actually resulted in weight gain. On the other hand, it has been discussed that short sleep duration induced obesity through appetite-related hormones such as leptin and ghrelin. In addition, it has been reported that OSA induced short sleep duration.

Conclusions

Thus, to consider the relationship between OSA and obesity, it is important to know the reciprocal relationships among OSA, obesity, and short sleep duration.
Literatur
1.
• Heinzer R, Vat S, Marques-Vidal P, Marti-Soler H, Andries D, Tobback N, et al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med. 2015;3:310–8. This manuscript showed a recent prevalence of sleep disordered breathing in a cohort.CrossRefPubMedPubMedCentral
2.
• Namen AM, Chatterjee A, Huang KE, Feldman SR, Haponik EF. Recognition of sleep apnea is increasing. Analysis of trends in two large, representative databases of outpatient practice. Ann Am Thorac Soc. 2016;13:2027–34. The increased trend of sleep disordered breathings was shown.CrossRefPubMed
3.
Pillar G, Shehadeh N. Abdominal fat and sleep apnea: the chicken or the egg? Diabetes Care. 2008;31(Suppl 2):S303–9.CrossRefPubMed
4.
Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Nieto FJ, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001;163:19–25.CrossRefPubMed
5.
Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365:1046–53.CrossRefPubMed
6.
Cefalu WT, Bray GA, Home PD, Garvey WT, Klein S, Pi-Sunyer FX, et al. Advances in the science, treatment, and prevention of the disease of obesity: reflections from a Diabetes Care editors’ expert forum. Diabetes Care. 2015;38(8):1567–82.CrossRefPubMedPubMedCentral
7.
8.
Jordan AS, McSharry DG, Malhotra A. Adult obstructive sleep apnoea. Lancet. 2014;383(9918):736–47.CrossRefPubMed
9.
Taheri S, Lin L, Austin D, Young T, Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med. 2004;1:e62.CrossRefPubMedPubMedCentral
10.
Buxton OM, Marcelli E. Short and long sleep are positively associated with obesity, diabetes, hypertension, and cardiovascular disease among adults in the United States. Soc Sci Med. 2010;71:1027–36.CrossRefPubMed
11.
Cappuccio FP, Cooper D, D'Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J. 2011;32:1484–92.CrossRefPubMed
12.
13.
Gallicchio L, Kalesan B. Sleep duration and mortality: a systematic review and meta-analysis. J Sleep Res. 2009;18:148–58.CrossRefPubMed
14.
Cappuccio FP, D'Elia L, Strazzullo P, Miller MA. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep. 2010;33:585–92.CrossRefPubMedPubMedCentral
15.
Lauderdale DS, Knutson KL, Yan LL, Liu K, Rathouz PJ. Self-reported and measured sleep duration: how similar are they? Epidemiology. 2008;19:838–45.CrossRefPubMedPubMedCentral
16.
Aziz M, Ali SS, Das S, Younus A, Malik R, Latif MA, et al. Association of subjective and objective sleep duration as well as sleep quality with non-invasive markers of sub-clinical cardiovascular disease (CVD): a systematic review. J Atheroscler Thromb. 2017;24:208–26.CrossRefPubMedPubMedCentral
17.
Chin K, Oga T, Takahashi K, Takegami M, Nakayama-Ashida Y, Wakamura T, et al. Associations between obstructive sleep apnea, metabolic syndrome, and sleep duration, as measured with an actigraph, in an urban male working population in Japan. Sleep. 2010;33:89–95.CrossRefPubMedPubMedCentral
18.
Risso TT, Poyares D, Rizzi CF, Pulz C, Guilleminault C, Tufik S, et al. The impact of sleep duration in obstructive sleep apnea patients. Sleep Breath. 2013;17:837–43.CrossRefPubMed
19.
Gangwisch JE, Malaspina D, Boden-Albala B, Heymsfield SB. Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep. 2005;28:1289–96.CrossRefPubMed
20.
Kohatsu ND, Tsai R, Young T, Vangilder R, Burmeister LF, Stromquist AM, et al. Sleep duration and body mass index in a rural population. Arch Intern Med. 2006;166:1701–5.CrossRefPubMed
21.
Spiegel K, Tasali E, Penev P, Van Cauter E. Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med. 2004;141:846–50.CrossRefPubMed
22.
Moraes W, Poyares D, Zalcman I, de Mello MT, Bittencourt LR, Santos-Silva R, et al. Association between body mass index and sleep duration assessed by objective methods in a representative sample of the adult population. Sleep Med. 2013;14:312–8.CrossRefPubMed
23.
Morgenthaler T, Alessi C, Friedman L, Owens J, Kapur V, Boehlecke B, et al. Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007. Sleep. 2007;30:519–29.CrossRefPubMed
24.
Shimizu K, Chin K, Nakamura T, Masuzaki H, Ogawa Y, Hosokawa R, et al. Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome. Thorax. 2002;57:429–34.CrossRefPubMedPubMedCentral
25.
Takahashi K, Chin K, Akamizu T, Morita S, Sumi K, Oga T, et al. Acylated ghrelin level in patients with obstructive sleep apnoea before and after nasal CPAP treatment. Respirology. 2008;13:810–6.CrossRefPubMed
26.
Chihara Y, Akamizu T, Azuma M, Murase K, Harada Y, Tanizawa K, et al. Among metabolic factors, significance of fasting and postprandial increases in acyl and desacyl ghrelin and the acyl/desacyl ratio in obstructive sleep apnea before and after treatment. J Clin Sleep Med. 2015;11:895–905.PubMedPubMedCentral
27.
Matsumoto T, Harada N, Azuma M, Chihara Y, Murase K, Tachikawa R, et al. Plasma Incretin levels and dipeptidyl peptidase-4 activity in patients with obstructive sleep apnea. Ann Am Thorac Soc. 2016;13:1378–87.CrossRefPubMed
28.
Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334:292–5.CrossRefPubMed
29.
Chin K, Shimizu K, Nakamura T, Narai N, Masuzaki H, Ogawa Y, et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation. 1999;100:706–12.CrossRefPubMed
30.
Ip MS, Lam KS, Ho C, Tsang KW, Lam W. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest. 2000;118:580–6.CrossRefPubMed
31.
Romero-Corral A, Caples SM, Lopez-Jimenez F, Somers VK. Interactions between obesity and obstructive sleep apnea: implications for treatment. Chest. 2010;137:711–9.CrossRefPubMedPubMedCentral
32.
Phillips BG, Hisel TM, Kato M, Pesek CA, Dyken ME, Narkiewicz K, et al. Recent weight gain in patients with newly diagnosed obstructive sleep apnea. J Hypertens. 1999;17:1297–300.CrossRefPubMed
33.
Ong CW, O’Driscoll DM, Truby H, Naughton MT, Hamilton GS. The reciprocal interaction between obesity and obstructive sleep apnoea. Sleep Med Rev. 2013;17:123–31.CrossRefPubMed
34.
Grunstein RR, Dodd MJ, Costas L, Sullivan CE. Home nasal CPAP for sleep apnea-acceptance of home therapy and its usefulness. Aust NZ J Med. 1986;16:635.
35.
Redenius R, Murphy C, O’Neill E, Al-Hamwi M, Zallek SN. Does CPAP lead to change in BMI? J Clin Sleep Med. 2008;4:205–9.PubMedPubMedCentral
36.
Quan SF, Budhiraja R, Clarke DP, Goodwin JL, Gottlieb DJ, Nichols DA, et al. Impact of treatment with continuous positive airway pressure (CPAP) on weight in obstructive sleep apnea. J Clin Sleep Med. 2013;9:989–93.PubMedPubMedCentral
37.
Keenan BT, Maislin G, Sunwoo BY, Arnardottir ES, Jackson N, Olafsson I, et al. Obstructive sleep apnoea treatment and fasting lipids: comparative effectiveness study. Eur Respir J. 2014;44:405–14.CrossRefPubMed
38.
•• Drager LF, Brunoni AR, Jenner R, Lorenzi-Filho G, Benseñor IM, Lotufo PA. Effects of CPAP on body weight in patients with obstructive sleep apnoea: a meta-analysis of randomised trials. Thorax. 2015;70:258–64. A meta-analysis which showed a significant body weight increase in patients with obstructive sleep apnea following CPAP treatment.CrossRefPubMed
39.
•• Tachikawa R, Ikeda K, Minami T, Matsumoto T, Hamada S, Murase K, et al. Changes in energy metabolism after continuous positive airway pressure for obstructive sleep apnea. Am J Respir Crit Care Med. 2016;194:729–38. Three months of CPAP therapy reduced the basal metabolic rate in the absence of changes in physical activity.CrossRefPubMed
40.
Iftikhar IH, Hoyos CM, Phillips CL, Magalang UJ. Meta-analyses of the association of sleep apnea with insulin resistance, and the effects of CPAP on HOMA-IR, adiponectin, and visceral adipose fat. J Clin Sleep Med. 2015;11:475–85.PubMedPubMedCentral
41.
Hoyos CM, Sullivan DR, Liu PY. Effect of CPAP on the metabolic syndrome: a randomised sham-controlled study. Thorax. 2013;68:588–9.CrossRefPubMed
42.
Sivam, S., Phillips, C.L., Trenell, M.I., Yee, B.J., Liu, P.Y., Wong, K.K., Grunstein. R.R. Effects of 8 weeks of continuous positive airway pressure on abdominal adiposity in obstructive sleep apnoea. Eur Respir J 2012; 40:913–918.
43.
Kritikou I, Basta M, Tappouni R, Pejovic S, Fernandez-Mendoza J, Nazir R, et al. Sleep apnoea and visceral adiposity in middle-aged male and female subjects. Eur Respir J. 2013;41:601–9.CrossRefPubMed
44.
Weinstock TG, Wang X, Rueschman M, Ismail-Beigi F, Aylor J, Babineau DC, et al. A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea. Sleep. 2012;35:617–25.CrossRefPubMedPubMedCentral
45.
Trenell MI, Ward JA, Yee BJ, Phillips CL, Kemp GJ, Grunstein RR. Influence of constant positive airway pressure therapy on lipid storage, muscle metabolism and insulin action in obese patients with severe obstructive sleep apnoea syndrome. Diabetes Obes Metab. 2007;9:679–87.CrossRefPubMed
46.
Münzer T, Hegglin A, Stannek T, Schoch OD, Korte W, Büche D, et al. Effects of long-term continuous positive airway pressure on body composition and IGF1. Eur J Endocrinol. 2010;162:695–704.CrossRefPubMed
47.
• Rosenzweig I, Glasser M, Polsek D, Leschziner GD, Williams SC, Morrell MJ. Sleep apnoea and the brain: a complex relationship. Lancet Respir Med. 2015;3:404–14. This review focused the associations between sleep apnea and brain function, which area would become an important research area in the future.CrossRefPubMed
48.
Chin K. Overcoming sleep disordered breathing and ensuring sufficient good sleep time for a healthy life expectancy. Proc Jpn Acad Ser B Phys Biol Sci. 2017;93:609–29.CrossRefPubMedPubMedCentral
Metadaten
Titel
Reciprocal Interactions Among OSA, Obesity, and Sleep Duration
verfasst von
Kazuo Chin
Ryo Tachikawa
Publikationsdatum
01.06.2018
Verlag
Springer International Publishing
Erschienen in
Current Oral Health Reports / Ausgabe 2/2018
Elektronische ISSN: 2196-3002
DOI
https://doi.org/10.1007/s40496-018-0176-0

Weitere Artikel der Ausgabe 2/2018

Current Oral Health Reports 2/2018 Zur Ausgabe

Oral Disease and Nutrition (F Nishimura, Section Editor)

Vitamin Status and Mineralized Tissue Development

Digital and Esthetic Dentistry (E Anadioti and P Stathopoulou, Section Editors)

Current and Emerging Applications of 3D Printing in Restorative Dentistry

Oral Disease and Nutrition (F Nishimura, Section Editor)

Periodontal Host Response in Subjects with Obesity

Digital and Esthetic Dentistry (E Anadioti and P Stathopoulou, Section Editors)

CAD/CAM Custom Abutments for Esthetic Anterior Implant-Supported Restoration: Materials and Design

Digital and Esthetic Dentistry (E Anadioti and P Stathopoulou, Section Editors)

CAD/CAM and 3D-printing Applications for Alveolar Ridge Augmentation

Digital and Esthetic Dentistry (E Anadioti and P Stathopoulou, Section Editors)

Virtual Dental Patient: How Long Until It’s Here?

Neu im Fachgebiet Zahnmedizin

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Parodontalbehandlung verbessert Prognose bei Katheterablation

19.04.2024 Vorhofflimmern Nachrichten

Werden Personen mit Vorhofflimmern in der Blanking-Periode nach einer Katheterablation gegen eine bestehende Parodontitis behandelt, verbessert dies die Erfolgsaussichten. Dafür sprechen die Resultate einer prospektiven Untersuchung.

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise